• GSK J4 HCl: Advanced JMJD3 Inhibitor Workflows in Epigenetic

  2026-07-30

  GSK J4 HCl, a potent and cell-permeable JMJD3 inhibitor, streamlines experimental design in chromatin and inflammatory research. This guide translates recent breakthroughs into actionable assay strategies, with protocol parameters and troubleshooting tips for robust, reproducible results.

• DRP1 Activation Links Mitochondrial Fission and Glycolysis i

  2026-07-30

  This study uncovers how hyperoxia-driven activation of DRP1 in alveolar type II (ATII) cells promotes mitochondrial fission and reprograms glucose metabolism, contributing to the pathology of bronchopulmonary dysplasia (BPD). The findings highlight DRP1 as a potential therapeutic target and provide methodological insight for metabolic and imaging studies in pulmonary research.

• SMPD4-Driven Sphingolipid Metabolism in Brain and Cilia Deve

  2026-07-29

  This study demonstrates that SMPD4-mediated sphingolipid metabolism is essential for brain and primary cilia development, with ceramide deficiency underpinning severe neurodevelopmental disorders. The findings elucidate a mechanistic link between lipid metabolism and neural progenitor survival, shaping future research directions in neurodevelopmental disease models.

• Methyl-β-cyclodextrin: Technical Use and Protocol Parameters

  2026-07-29

  Methyl-β-cyclodextrin is a high-purity reagent for extracting cholesterol and specific lipids from cellular membranes, supporting studies of membrane fluidity, lipid raft disruption, and cholesterol-dependent signaling. It is not suitable for diagnostic or therapeutic applications and demands precise handling for reliable research outcomes.

• Cefiderocol vs. β-Lactam Combinations: Enterobacterales Resi

  2026-07-28

  This study delivers a comprehensive assessment of cefiderocol's in vitro activity against European Enterobacterales, including meropenem- and β-lactam/β-lactamase inhibitor-resistant isolates. The findings provide a benchmark for alternative treatment strategies and highlight the importance of early susceptibility testing for resistant Gram-negative pathogens.

• Thymoquinone: Optimizing Cardiotoxicity Assays with Precisio

  2026-07-28

  Thymoquinone, a bioactive quinone from Nigella sativa, is redefining preclinical models of chemotherapy-induced cardiac injury through Nrf2/HO-1 pathway activation and potent anti-ferroptotic effects. Explore rigorous experimental workflows, actionable troubleshooting, and comparative innovation using APExBIO's high-purity thymoquinone for robust cardiovascular research.

• 5-Azacytidine: Optimizing DNA Demethylation in Cancer Models

  2026-07-27

  5-Azacytidine (5-AzaC) is the gold-standard DNA demethylation agent—powerful for reactivating silenced genes, dissecting epigenetic mechanisms, and inducing apoptosis in leukemia and myeloma models. This guide delivers workflow enhancements, real-world troubleshooting, and actionable protocol parameters to maximize reproducibility in advanced cancer research.

• Acridine Orange hydrochloride: Technical Parameters & Workfl

  2026-07-27

  Acridine Orange hydrochloride offers specific, dual-fluorescence staining for DNA and RNA, supporting cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is not suitable for protocols requiring non-permeant stains or long-term solution storage. This article details practical set-up, QC, and troubleshooting for effective nucleic acid detection workflows.

• Halazone: Antimicrobial Sulfonamide for Disinfection & Neuro

  2026-07-26

  Halazone delivers dual utility as a rapid water disinfection agent and a powerful modulator of neuronal sodium channels. Its robust oxidative mechanism and validated parameters empower both microbiology and neurophysiology workflows, positioning it as a versatile tool for experimental reproducibility and innovation.

• Azathramycin A: Pharmacological Profiling and Assay Precisio

  2026-07-25

  Explore the advanced pharmacological characterization of Azathramycin A, a macrolide antibiotic, with an emphasis on deeper assay design and translational research clarity. This article uniquely bridges PK/PD insights and methodological rigor for tuberculosis research models.

• Y-27632: Selective ROCK Inhibitor for Cytoskeletal Modulatio

  2026-07-24

  Y-27632 is a selective ROCK inhibitor widely used to modulate cytoskeletal dynamics in cell biology research. It targets ROCK1 and ROCK2 with high specificity, enabling reproducible disruption of actin stress fibers. The compound's robust performance and well-defined protocol parameters make it a benchmark tool for studies on cell morphology and ROCK signaling.

• MDM1 Overexpression Enhances Chemoradiotherapy Response in C

  2026-07-24

  The referenced study demonstrates that MDM1 overexpression increases p53 levels and apoptosis, sensitizing colorectal cancer cells to chemoradiotherapy. These mechanistic insights establish MDM1 as a potential predictive marker for therapy response and suggest new strategies for overcoming resistance.

• Rhodamine B Applications: Drift Tracing & Cell Labeling Adva

  2026-07-23

  Rhodamine B (Basic Violet 10) is a versatile fluorescent dye enabling both large-scale environmental drift assessments and high-sensitivity cell imaging. This article delivers stepwise protocols, troubleshooting strategies, and evidence-based insights that empower researchers to optimize workflows from field to benchtop.

• Cy5 amine (non-sulfonated): Technical Guidance and Protocols

  2026-07-23

  Cy5 amine (non-sulfonated) addresses the need for a bright, photostable, amine-reactive cyanine dye in workflows requiring water-insoluble fluorescent labeling of proteins, peptides, or polymers. It is not intended for direct aqueous labeling or any diagnostic or medical application, demanding careful attention to solvent compatibility and storage parameters.

• HBTU in Peptide Synthesis: Mechanistic Insights and Next-Gen

  2026-07-22

  Explore the mechanistic role of HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) in advanced peptide synthesis. This article offers a deep scientific analysis of racemization resistance, carboxylic acid activation, and the implications for emerging cancer-selective peptide therapeutics.

10322 records 2/689 page Previous Next 12345 下5页 Last page